LIDOCAINE HYDROCHLORIDE INJECTIO
DIBBS awards by month · trailing 12 mo
3 total
Price to win
From deduped DIBBS award lines (unit cost × quantity). Not a bid recommendation — observed history only.
Average unit cost
$74.28
Weighted average
$58.28
Weighted by quantity
Observed range
$46.49–$259
Coverage
20 awards
Dec 1, 2020 – Jul 22, 2026
Average: $74.28 · Weighted avg: $58.28 · Range: $46.49–$259.43 · Based on 20 awards, Dec 1, 2020–Jul 22, 2026.
Unit cost by award date · 20 priced lines
DIBBS award history
Distinct award lines for this NSN (deduped). Line total is unit cost × quantity.
20 distinct award lines
| Date | Manufacturer | Qty × unit | Total | Contract |
|---|---|---|---|---|
| Jul 22, 2026 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 3 × $47.02 | $141 | SPE2DP26F7971 |
| Jul 11, 2026 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 4 × $47.02 | $188 | SPE2DP26F7313 |
| Feb 3, 2026 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 4 × $47.02 | $188 | SPE2DP26F2300 |
| Aug 20, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $47.33 | $47 | SPE2DP25F074H |
| Aug 11, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 8 × $47.33 | $379 | SPE2DP25F051HP00001 |
| Aug 11, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 8 × $47.33 | $379 | SPE2DP25F051DP00001 |
| Jul 23, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 6 × $47.33 | $284 | SPE2DP25F010J |
| Jul 8, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 3 × $47.33 | $142 | SPE2DP25F9308 |
| Jun 27, 2025 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 20 × $47.33 | $947 | SPE2DP25F8876P00001 |
| Apr 30, 2025 | 3W8H0MR UNLIMITED, LLCBRENHAM, TXSAM | 3 × $259.43 | $778 | SPE2DP25P0322 |
| Oct 7, 2024 | 3W8H0MR UNLIMITED, LLCBRENHAM, TXSAM | 1 × $214.21 | $214 | SPE2DP25V0047 |
| Oct 1, 2024 | 3W8H0MR UNLIMITED, LLCBRENHAM, TXSAM | 1 × $214.21 | $214 | SPE2DP25V0003 |
| Feb 15, 2024 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 4 × $46.49 | $186 | SPE2D924F1744 |
| Feb 9, 2023 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $46.49 | $93 | SPE2D923F1641 |
| Jun 4, 2021 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $46.49 | $93 | SPE2D921F2745 |
Manufacturers who have won this NSN
Distinct CAGEs with a confirmed DIBBS award line for this part — each opens the manufacturer page.
Approved manufacturers
Qualified to supply per MCRL — no confirmed DIBBS award on record for this NSN. Each CAGE opens the manufacturer page.
PN NDC00409-9137-05
PN NDC00409-9137-05
PN 04-1081
Characteristics
FLIS item characteristics from PUB LOG identification.
| Characteristic | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS LIDOCAINE HYDROCHLORIDE PER MILLILITER 10.000 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HYDROCHLORIDE 10 MG/ML 5ML 10S |
| PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 5.000 |
| PRIMARY CONTAINER TYPE | SYRINGE |
| SPECIAL FEATURES | LIDOCAINE INJECTION 1%, 10MG PER ML; 5ML; PKG/10; DISPOSABLE SYRINGE |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
Open buys
DIBBS · quotes by Sep 14, 2026 · UNRESTRICTED
